Abbott
Abbott Q4 Diagnostics Revenues Fall 26 Percent on Declining COVID-19 Sales
The company announced that its total revenues for the quarter declined 12 percent, while revenues for the full year rose 1 percent.
JP Morgan Healthcare Conference, Day 2: Thermo Fisher, Agilent, Roche, Seer, More
Highlights from the second day included Agilent's $725 million investment in nucleic acids manufacturing and Roche's development plans for an integrated mass spec platform.
The firm's core laboratory revenues fell 6 percent, while molecular sales were down 47 percent.
Abbott Gets FDA Emergency Use Authorization for Monkeypox PCR Test
The FDA granted authorization for the Alinity m MPXV assay, Abbott's real-time PCR test using human lesion swab specimens.
In Brief This Week: Thermo Fisher Scientific, DNAnexus, Precipio, Delfi Diagnostics, Streck, More
News items for the week of Sept. 12, 2022.